Navigation Links
Cepheid to Webcast Analyst Event
Date:7/21/2008

Management presentations to be hosted at 2008 American Association for

Clinical Chemistry Annual Meeting

SUNNYVALE, Calif., July 21 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today invited investors to participate in the Company's Analyst Reception which is being hosted in Washington, D.C. ahead of the 2008 American Association for Clinical Chemistry (AACC) Annual Meeting.

Cepheid speakers will include Chief Executive Officer John Bishop, Chief Medical and Technology Officer David Persing, Chief Operations Officer Humberto Reyes, Senior Vice President of Worldwide Commercial Operations, Rob Koska, and Chief Financial Officer Andrew Miller.

Investors and interested parties are welcome to access the live webcast that will be available starting at 5:30 p.m. Eastern Time on Monday, July 28, 2008. The program is expected to last up to three hours. To access the live webcast, please visit Cepheid's website at http://www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the Company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market.

For Media Inquiries:

Jared Tipton

Cepheid Corporate Communications

Tel: (408) 400 8377

jared.tipton@cepheid.com

For Investor Inquiries:

Jacquie Ross

Cepheid Investor Relations

Tel: (408) 400 8329

jacquie.ross@cepheid.com


'/>"/>
SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
2. Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
3. Cepheid Market Reach Extended with Licenses in Canada and Registrations in Mexico
4. Cepheid Signs Group Purchasing Contract with Novation, the Nations Largest Healthcare Contracting Organization
5. Cepheid to Present at the Robert W. Baird Growth Stock Conference and the Bank of America Healthcare Conference
6. Cepheid Schedules Teleconference and Webcast for First Quarter 2008 Results
7. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
8. Cepheid Reports Fourth Quarter and Full Year 2007 Results
9. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
10. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
11. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... innovative medical technologies, services and solutions to the healthcare market. The company's primary ... various distribution, manufacturing, sales and marketing strategies that are necessary to help companies ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... discussions on a range of subjects including policies, debt and ... Poloz. Speaking at a lecture to the Canadian ... to the country,s inflation target, which is set by both ... "In certain areas there needs to be ... why not sit down and address strategy together?" ...
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
Breaking Biology Technology:
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):